1. Home
  2. NKTX vs EUDA Comparison

NKTX vs EUDA Comparison

Compare NKTX & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • EUDA
  • Stock Information
  • Founded
  • NKTX 2015
  • EUDA 2021
  • Country
  • NKTX United States
  • EUDA Singapore
  • Employees
  • NKTX N/A
  • EUDA N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • EUDA Blank Checks
  • Sector
  • NKTX Health Care
  • EUDA Finance
  • Exchange
  • NKTX Nasdaq
  • EUDA Nasdaq
  • Market Cap
  • NKTX 170.8M
  • EUDA 139.3M
  • IPO Year
  • NKTX 2020
  • EUDA N/A
  • Fundamental
  • Price
  • NKTX $1.71
  • EUDA $3.83
  • Analyst Decision
  • NKTX Strong Buy
  • EUDA
  • Analyst Count
  • NKTX 6
  • EUDA 0
  • Target Price
  • NKTX $15.00
  • EUDA N/A
  • AVG Volume (30 Days)
  • NKTX 2.5M
  • EUDA 102.5K
  • Earning Date
  • NKTX 05-08-2025
  • EUDA 01-01-0001
  • Dividend Yield
  • NKTX N/A
  • EUDA N/A
  • EPS Growth
  • NKTX N/A
  • EUDA N/A
  • EPS
  • NKTX N/A
  • EUDA N/A
  • Revenue
  • NKTX N/A
  • EUDA $3,811,496.00
  • Revenue This Year
  • NKTX N/A
  • EUDA $66.63
  • Revenue Next Year
  • NKTX N/A
  • EUDA $119.95
  • P/E Ratio
  • NKTX N/A
  • EUDA N/A
  • Revenue Growth
  • NKTX N/A
  • EUDA N/A
  • 52 Week Low
  • NKTX $1.31
  • EUDA $1.65
  • 52 Week High
  • NKTX $8.53
  • EUDA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 50.34
  • EUDA 51.00
  • Support Level
  • NKTX $1.42
  • EUDA $3.40
  • Resistance Level
  • NKTX $1.99
  • EUDA $4.04
  • Average True Range (ATR)
  • NKTX 0.19
  • EUDA 0.24
  • MACD
  • NKTX 0.01
  • EUDA 0.03
  • Stochastic Oscillator
  • NKTX 31.52
  • EUDA 61.43

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.

Share on Social Networks: